GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » Float Percentage Of Total Shares Outstanding

Pentixapharm Holding AG (XTER:PTP) Float Percentage Of Total Shares Outstanding : 0.00% (As of Apr. 14, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Pentixapharm Holding AG Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pentixapharm Holding AG's float shares is 0.00 Mil. Pentixapharm Holding AG's total shares outstanding is 24.80 Mil. Pentixapharm Holding AG's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pentixapharm Holding AG's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pentixapharm Holding AG's Institutional Ownership is 5.79%.

Pentixapharm Holding AG Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Pentixapharm Holding AG's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/24.80
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pentixapharm Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
STU:T9G XTER:HPHA XTER:MDG1 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM HKSE:02269 BMRN RPRX XKRX:196170 OCSE:GMAB
Traded in Other Exchanges
PTPN:Austria
Address
Robert-Rossle-Street 10, Berlin, DEU
Website
https://www.pentixapharm.com
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic.

Pentixapharm Holding AG Headlines

No Headlines